Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

被引:44
作者
Ciprandi, Giorgio [1 ]
Murdaca, Giuseppe [1 ]
Colombo, Barbara Maria [1 ]
De Amici, Mara [2 ]
Marseglia, Gialuigi L. [2 ]
机构
[1] Univ Genoa, Dept Internal Med, Azienda Osped Univ San Martino, I-16126 Genoa, Italy
[2] Univ Pavia, Dept Pediat Sci, Pediat Clin, Fdn IRCCS San Matteo, I-27100 Pavia, Italy
关键词
VEGF; Th1; Th2; allergic rhinitis; systemic lupus; erythematosus;
D O I
10.1016/j.humimm.2008.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Allergic rhinitis (AR) is characterized by an inflammatory reaction sustained by Th2 polarization, whereas systemic lupus erythematosus (SLE) is a typical autoimmune disorder. Vascular endothelial growth factor (VEGF) is a critical mediator of inflammation. The aim of this study was to compare serum VEGF levels in three groups of subjects: 40 normal subjects, 40 allergic patients, evaluated before and after specific immunotherapy, and 40 patients with inactive SLE. Patients who were allergic before immunotherapy had the lowest VEGF serum levels, which significantly increased after treatment; SLE patients had the highest VEGF serum levels. This comparative study provides evidence that serum VEGF levels depend on the type of immune response: they are high in autoimmune disease and low in Th2-polarized allergic reaction. The relevance of this phenomenon is further apparent, as it is also observed in patients with inactive disease. (C) 2008 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:510 / 512
页数:3
相关论文
共 10 条
[1]   Increased expression of vascular endothelial growth factor-a in seasonal allergic rhinitis [J].
Benson, M ;
Carlsson, B ;
Carlsson, LMS ;
Wennergren, G ;
Cardell, LO .
CYTOKINE, 2002, 20 (06) :268-273
[2]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[3]   Allergic rhinitis: A disease remodeling the upper airways? [J].
Bousquet, J ;
Jacquot, W ;
Vignola, AM ;
Bachert, C ;
Van Cauwenberge, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :43-49
[4]   Serum vascular endothelial growth factor and sublingual immunotherapy [J].
Ciprandi, G. ;
Colombo, B. M. ;
Murdaca, G. ;
De Amici, M. .
ALLERGY, 2008, 63 (07) :945-946
[5]   Vascular endothelial growth factor (VEGF) in autoimmune diseases [J].
Freire Carvalho, Jozelio ;
Blank, Miri ;
Shoenfeld, Yehuda .
JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) :246-256
[6]   Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities [J].
Kuryliszyn-Moskal, Anna ;
Klimiuk, Piotr Adrian ;
Sierakowski, Stanislaw ;
Ciolkiewicz, Mariusz .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (03) :179-185
[7]   Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung [J].
Lee, CG ;
Link, H ;
Baluk, P ;
Homer, RJ ;
Chapoval, S ;
Bhandari, V ;
Kang, MJ ;
Cohn, L ;
Kim, YK ;
McDonald, DM ;
Elias, JA .
NATURE MEDICINE, 2004, 10 (10) :1095-1103
[8]   Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus [J].
Robak, E ;
Sysa-Jedrzejewska, A ;
Robak, T .
MEDIATORS OF INFLAMMATION, 2003, 12 (05) :293-298
[9]   Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus [J].
Robak, E ;
Wozniacka, A ;
Sysa-Jedrzejowska, A ;
Stepien, H ;
Robak, T .
LUPUS, 2002, 11 (06) :348-355
[10]   Vascular remodelling in asthma [J].
Walters, Eugene Haydn ;
Soltani, Amir ;
Reid, David William ;
Ward, Chris .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 8 (01) :39-43